BTLA anticorps (PE)
Aperçu rapide pour BTLA anticorps (PE) (ABIN2212728)
Antigène
Voir toutes BTLA AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Réactivité croisée
- Humain
-
Réactivité croisée (Details)
- Calculated cross reactivity: Hu
-
Attributs du produit
- BTLA (B- and T-lymphocyte Associated Protein, B- and T-lymphocyte Attenuator, BTLA1, CD272, CD272 Antigen, FLJ16065, MGC129743) (PE)
-
Purification
- Purified by Protein A affinity chromatography.
-
Immunogène
- Recombinant corresponding to soluble human CD272.
-
Isotype
- IgG1 kappa
-
-
-
-
Indications d'application
- Optimal working conditions should be determined by the investigator.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Supplied as a liquid in 50 mM sodium phosphate, pH 7.5, 100 mM potassium chloride, 150 mM sodium chloride, 0.2 % BSA, 0.04 % sodium azide, 5 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- 4°C ,Do Not Freeze
-
-
- BTLA (B and T Lymphocyte Associated (BTLA))
-
Autre désignation
- BTLA
-
Pathways
- Cancer Immune Checkpoints
Antigène
-